Skip to content

Gili Pro BioSensor (also known as Gili BioSensor System)

by Continuse Biometrics, Ltd.

De Novo DEN200038

Active United States

De Novo

Valid until

No expiry

De Novo grant is not time-limited

FDA recalls

None found

in data synced 26 Oct 2026

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA De Novo, synced 26 Oct 2026. What this means

Regulatory status

as of registry sync 26 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA De NovoDENG De Novo granted · Direct NumberDEN200038 Date1 Apr 2021DecidedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 26 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA De Novo Active

Specification

De Novo

De Novo Number
FDA Product Code
QOK
FDA applicant
Continuse Biometrics , Ltd.
Device Class
Class II
Regulation
21 CFR Part 870.2786
Advisory Committee
Cardiovascular
FDA Decision
DENG De Novo granted